Doxepin Capsules   3

Background
The Department of Veterans Affairs (VA) and the Department of Defense (DOD) acquire their pharmaceutical requirements through their respective Pharmaceutical Prime Vendor (PPV) Programs. The PPV Programs are separate contracts that establish the fees for the distribution of pharmaceutical products on Federal Government contracts. The purpose of this solicitation is to establish a supply source that will provide the drugs listed in the schedule for purchase through the PPV Programs. The objective is to ensure availability and consistency of product for nationwide usage and to obtain volume-based, committed-use pricing.

Work Details
The contract is for the supply of Doxepin Capsules, with specific details provided for each line item including quantity, unit, unit price, and amount for the base year and four option years. Offerors must submit a price for all line items offered, inclusive of the base year and all option years. Offered prices must include a 0.50% Cost Recovery Fee as outlined in the Scope of Contract (paragraph 11).

Period of Performance
The contract will be effective on the date the government signs the SF1449 and notifies the offeror (contractor) of award. The Implementation Period begins at the Contract Effective Date and ends at the start of the Ordering Period, which will be in effect for one year.

Place of Performance
Products will be ordered by VA through Government Prime Vendor contracts. Delivery order requirements such as product quantities, time and place of delivery, and method of delivery for product(s) awarded on resultant contract(s) will be determined between the awarded contractor(s) and Government Prime Vendor contractors.